About Ryzer Pharmaceutical Private Limited
Data last updated:
Ryzer Pharmaceutical Private Limited is a private limited company based in Gandhinagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC104523. Its GSTIN is 24AAJCR1753M1Z3 (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Pramukhbhai Dahyabhai Patel and Ravikumar Dashrathbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 901 Gandhinagar Mansa Road Opp. Raj Bglw. Dholakuva Village Mansa, Gujarat, India – 382845.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.71 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net loss of ₹2.12 Cr (net margin -27.6%) and EBITDA of -₹1.3 Cr (EBITDA margin -16.8%).
As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹2 Cr on record.
For more details, the company can be reached via its website ryzerpharma.com.
Company details
Contact details
Ryzer Pharmaceutical Private Limited's registered office is in Gandhinagar, Gujarat. Its website is ryzerpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 901 Gandhinagar Mansa Road Opp. Raj Bglw. Dholakuva Village Mansa, Gujarat, India – 382845
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ryzer Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ryzer Pharmaceutical Private Limited
FY 2024 filings availableRyzer Pharmaceutical Private Limited reported revenue of ₹7.71 Cr (up 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 41% in the latest year. EBITDA fell 320% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -16.8% | ||||
| Net Profit Margin | -27.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ryzer Pharmaceutical Private Limited, buy the company report.
Board of directors of Ryzer Pharmaceutical Private Limited
Ryzer Pharmaceutical has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramukhbhai Dahyabhai Patel Also directs: Shankheshwar Infracon Private Limited, Shreerang Hospitality LLP, Yas Infracon LLP and 2 more | Director | 15 Oct 2023 | 3 Years 0 Months | Current |
| Ravikumar Dashrathbhai Patel | Director | 05 Feb 2024 | 2 Years 8 Months | Current |
| Brijesh Rajendrakumar Patel Also directs: Trentium Lifesciences Private Limited | Director | 15 Oct 2023 | 3 Years 0 Months | Current |
| Payank Jayantibhai Patel Also directs: JD Buildmart LLP, Lavish Foods Private Limited, Shri Rang Infrastructure Private Limited and 1 more | Director | 22 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Ryzer Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alkon Formulation Private Limited | ₹7.74 Cr (FY 2024) | -30.0% | Baddi, Himachal Pradesh, India | |||
| R K G Pharma Pvt Ltd | ₹7.73 Cr (FY 2025) | 20.0% | New Delhi, Delhi, India | |||
| Suvishrhu Speciality Chemicals Private Limited | ₹7.72 Cr (FY 2024) | 125.0% | Thane, Maharashtra, India | |||
| Alchemist Remedies Private Limited | ₹7.72 Cr (FY 2025) | -38.0% | Indore, Madhya Pradesh, India | |||
| Ryzer Pharmaceutical Private Limitedthis company | ₹7.71 Cr (FY 2025) | -₹2.12 Cr | -27.6% | 41.0% | Gandhinagar, Gujarat, India | |
| Globespeciality Chemicals Private Limited | ₹7.71 Cr (FY 2025) | 167.0% | Pune, Maharashtra, India | |||
| Sunny Industries Pvt Ltd | ₹7.68 Cr (FY 2025) | -3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Ryzer Pharmaceutical Private Limited, buy the company report.
Auditor
Ryzer Pharmaceutical Private Limited is audited by A P D & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A P D & Co | FY 2024 | 139178W |
Shareholding
The shareholding of Ryzer Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ryzer Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2025 | 101159202 | Others | ₹7.5 Cr | Open | |
| 13 Nov 2024 | 101016284 | Others | ₹2 Cr | Satisfied |
To see the full charge records of Ryzer Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ryzer Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ryzer Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ryzer Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCR1753M1Z3 | Gujarat | Active | 27 Dec 2018 |
To see the full GST registrations and return filing status of Ryzer Pharmaceutical Private Limited, buy the company report.
Recent activity
Ryzer Pharmaceutical Private Limited has 8 board changes on record since 2021: 4 appointments and 4 cessations. The latest: Bhikhabhai Patel Dahyalal ceased to be Director on 26 Mar 2024.
2 earlier events are in the company report.
Frequently asked questions
Ryzer Pharmaceutical is an active private limited company based in Gandhinagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 October 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC104523.
Ryzer Pharmaceutical has 4 current directors:
- Pramukhbhai Dahyabhai Patel - Director
- Ravikumar Dashrathbhai Patel - Director
- Brijesh Rajendrakumar Patel - Director
- Payank Jayantibhai Patel - Director
The latest financial statements of Ryzer Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ryzer Pharmaceutical is 24AAJCR1753M1Z3, registered in Gujarat.
The CIN (Corporate Identification Number) of Ryzer Pharmaceutical is U74999GJ2018PTC104523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ryzer Pharmaceutical was incorporated on 01 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ryzer Pharmaceutical by revenue are Alkon Formulation Private Limited, R K G Pharma Pvt Ltd, Suvishrhu Speciality Chemicals Private Limited, Alchemist Remedies Private Limited, Globespeciality Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhikhabhai Patel Dahyalal ceased to be Director on 26 Mar 2024. Bharatkumar Ghelabhai Patel ceased to be Director on 23 Mar 2024. Ravikumar Dashrathbhai Patel was appointed as Director on 05 Feb 2024. Ryzer Pharmaceutical has 8 board changes on record in total.
Ryzer Pharmaceutical can be reached through the website ryzerpharma.com. Its registered office is in Gandhinagar, Gujarat, India.
The registered office of Ryzer Pharmaceutical is at Plot No. 901 Gandhinagar Mansa Road Opp. Raj Bglw. Dholakuva Village Mansa, Gujarat, India – 382845.
Ryzer Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.